ADMA Biologics faces lead plaintiff deadline August 10 as investors urged to apply for securities class action
Executive summary: ClaimsFiler reminded investors with losses over $100,000 that they have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit against ADMA Biologics, Inc. The lead plaintiff selection can shape litigation strategy, settlement talks, and ultimately affect ADMA's financial exposure and stock price.
Who is involved: ADMA Biologics, ClaimsFiler, investors holding ADMA shares with >$100,000 losses, and the court overseeing the class action.
Likely next: Investors will submit applications by the August 10 deadline; the court will then select a lead plaintiff, after which the case will proceed to discovery and potential settlement discussions.
ClaimsFiler has issued a reminder that investors who suffered losses exceeding $100,000 in ADMA Biologics must submit lead plaintiff applications by August 10, 2026 in an ongoing securities class action. The notice follows a previously filed lawsuit alleging securities fraud related to revenue inflation. Meeting the deadline is a prerequisite for being considered as the lead plaintiff, a role that can influence the direction and potential settlement of the litigation.
Timeline
- — ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA (PR Newswire)
- — Hub Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hub Group - HUBG (PR Newswire)
- — PicS Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PicS N.V. - PICS (PR Newswire)
- — GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS (PR Newswire)
- — Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Erasca - ERAS (PR Newswire)
Analysis — what this means
Likely next events
- August 10, 2026: Lead plaintiff application deadline for ADMA Biologics class action
- August 10, 2026: Same deadline for Erasca and GeneDx class actions (ClaimsFiler reminders)
- July 27, 2026: Lead plaintiff deadline for AeroVironment class action
Sectors affected
- Biotechnology
- Biologics
- Healthcare
Regulatory implications
- Private Securities Litigation Reform Act (PSLRA) governs lead plaintiff selection; missing the deadline bars investor from serving as lead plaintiff
- Successful class action could trigger SEC scrutiny of ADMA's revenue recognition practices
Historical parallels
- 2021 Facebook securities class action lead plaintiff deadline (August 2021)
- 2018 Tesla shareholder derivative lawsuit lead plaintiff selection process
Key entities
Sources
Open the full interactive case file on Beyond →
INTELLIGENCE
Social Pulse
AI estimate · not scraped